Ginegar's Real Cash: Inventory, Short-Term Debt, and Covenant Headroom

The main article argued that Ginegar's 2025 should not be judged by sales momentum, but by cash conversion quality. This follow-up isolates that question. The issue here is not how much cash sat in the bank on December 31, but how much real flexibility was left after combining working capital, investment, leases, dividends, short-term debt, and the covenant package.

Four points matter once the bridge is broken down. First, this is not only an inventory problem. Inventory is still heavy and material, but the 2025 cash drag also came from receivables and from a sharp drop in supplier credit. Second, the move into short-term funding was not a December cosmetic effect. The annual averages show that the shift ran through the year. Third, there is real covenant room. Ginegar was not operating on the edge. Fourth, that room is not the same thing as free cash. It rests on short-term credit lines, some of which are described without signed framework agreements.

That last point is the core of the read. A company can sit comfortably inside its covenants and still depend heavily on bank rollover and on working-capital behavior. That is exactly what needs to be measured here.

The Real Cash Bridge

To avoid flattering 2025, the right frame here is all-in cash flexibility. Ginegar does not disclose maintenance capex, so there is no clean way to build a normalized cash-generation number without inserting an analyst estimate. In that situation, the honest framing is the actual cash bridge.

That chart captures most of the story. Net profit of NIS 4.1 million plus NIS 39.9 million of non-cash adjustments created roughly NIS 44.0 million before working capital, interest, and tax. But then two holes opened. Working-capital movements consumed NIS 40.7 million, and net cash interest and tax consumed another NIS 20.8 million. The result is the number that matters more than the income statement headline: operating cash flow of negative NIS 17.4 million in a year that still ended with positive net income.

The picture becomes even sharper from there. After operating cash flow, Ginegar still had NIS 30.0 million of investing outflow, NIS 15.0 million of dividends, NIS 36.5 million of long-term debt repayments, and NIS 6.3 million of lease-principal repayments. In other words, before fresh financing, 2025 required well over NIS 100 million of funding. That gap was covered by NIS 18.3 million of new long-term borrowing and, mainly, by NIS 86.4 million of net short-term bank credit. That is why cash fell by only NIS 2.6 million, from NIS 86.8 million to NIS 84.3 million. This was not a cash-generation year. It was a funding-bridge year.

What matters is that management says explicitly that during 2025 it chose not to raise new long-term debt or extend existing facilities, because it expected lower interest rates, and financed most of the group's activity, including longer-term investment, through short-term credit. That is a tactical decision one can understand, but in hindsight it left the company more dependent on cash that was not really free.

Working Capital: Not Just Inventory

The first instinct of most readers will be to blame inventory. That is understandable, but incomplete. Year-end inventory still stood at NIS 168.8 million, and the auditors flagged it as a key audit matter. After provisions, inventory amounted to roughly NIS 169 million, about a quarter of total assets. The company also says average finished-goods inventory stands at about 120 days, including stock held in forward warehouses in target markets. That is heavy, and it needs financing.

But 2025 did not get stuck only there.

Those numbers tell a more complicated story than the word inventory. Receivables rose to NIS 186.2 million, and the cash-flow statement shows NIS 14.6 million disappearing there. Other receivables added another NIS 2.8 million of outflow. Inventory actually fell modestly on the balance sheet, from NIS 174.0 million to NIS 168.8 million, yet it still absorbed NIS 5.6 million in the cash-flow bridge. On the other side of the equation, payables to suppliers fell by NIS 31.5 million, translating into NIS 16.3 million of cash outflow.

That is why the 2025 story is not "inventory swelled, therefore cash disappeared." The more accurate read is that the company financed more customer credit, received materially less supplier credit, and at the same time kept inventory at a level that remained very heavy. When all three happen together, even a company that is still selling can suddenly look much less flexible.

The credit-day data makes the point sharper. Average customer days rose from 105 to 108. That looks minor on paper, but against revenue of more than NIS 628 million it is already meaningful. On the other side, average supplier days fell from 148 to 113. That is not a side note. It is a change in financing terms inside the value chain. Put simply, Ginegar gave the customer a bit more time and got much less time from the supplier. The cash in the middle had to come from somewhere else.

This is where inventory returns to the story, but in the right place. The company says that in quantitative terms inventory did not change materially, and that the money-value picture was also affected by inventory composition and by market mix. That matters because it explains how one can see a modest decline in balance-sheet inventory and still see cash absorbed by inventory in the flow statement. Inventory is not the whole story, but it remains the heavy anchor around which the rest of working capital turns.

Short-Term Funding: The Shift Was Not Cosmetic

If 2025 were only a year-end snapshot, one could argue that short-term bank debt merely spiked in December for a technical reason. The annual averages rule that out.

The standout number is the jump in average short-term borrowing, from NIS 26.0 million to NIS 74.5 million. At the same time, average long-term borrowing fell from NIS 160.7 million to NIS 126.3 million. Average supplier credit also fell, from NIS 152.6 million to NIS 145.0 million, while average customer credit rose to NIS 181.9 million. This is not random balance-sheet noise around the reporting date. It is a genuine change in the way the business was funded.

The year-end balance sheet only intensifies that trend. Short-term bank credit rose to NIS 121.6 million from NIS 35.3 million a year earlier. Of that amount, NIS 67.0 million is unlinked and NIS 54.6 million is denominated in or linked to foreign currency. Even current maturities of long-term debt are not clean shekel liabilities, because NIS 22.3 million out of NIS 32.9 million is in foreign currency or linked to it.

So this is not just a short-versus-long question. It is also a currency question. The company closes 2025 with excess monetary liabilities over monetary assets of NIS 59.0 million in US dollars and NIS 52.2 million in euros, alongside CPI-linked excess liabilities of NIS 38.9 million. It does have excess assets in Indian rupees, Brazilian reais, and Moroccan dirhams, and it hedges selectively from time to time, but in practice the 2025 funding bridge relied partly on short debt and partly on open currency exposure.

That is what makes the picture less comfortable than the closing cash balance suggests. Anyone looking only at NIS 84.3 million of cash misses the fact that much of that apparent calm was bought by moving funding from the longer layer to the shorter one, and partly into currency-linked debt.

Covenants: Real Cushion, Not Immunity

There is a clear positive point here: Ginegar was not close to breaching its financial covenants at year-end 2025. On the contrary, it finished the year with visible room across all four tests that the banks measure on an annual basis.

That table matters because it prevents exaggeration. There is no covenant sitting right on the wall. Even the test most relevant to the current thesis, net short-term credit versus operating working capital, was still not near emergency territory. The company also stresses that the covenants are tested only once a year, based on the annual statements.

But this is exactly where one has to stop and be precise. Covenant room is not the same thing as free liquidity. In Israel, the company describes an available short-term credit line of NIS 86 million at year-end and NIS 64 million on February 28, 2026. It presents a NIS 99 million cushion net of cash at year-end, and a NIS 93 million cushion at the end of February net of cash and short-term deposits. At the same time, it says there are no signed framework agreements, that line information was provided orally, and in its liquidity discussion it adds that drawdown with one of the three banks is subject to case-by-case approval. That is a meaningful distinction. The cushion exists, but its certainty is lower than that of a fully committed multi-year facility.

The contractual-liquidity table also demands discipline. First-year undiscounted obligations, including interest, stood at NIS 314.7 million. Of that, NIS 160.2 million was loans from banks and others, NIS 10.1 million was lease liabilities, NIS 125.2 million was trade payables, and NIS 19.3 million was other payables. Of course, not all of that is one immediate wall, because suppliers and accrued items roll as part of the operating cycle. Still, set against NIS 84.3 million of cash, the conclusion is straightforward: Ginegar's flexibility rests mainly on continued bank access and on working capital not worsening from here, not on idle cash sitting on the balance sheet.

What 2026 Has To Prove

The message of this continuation is not that Ginegar entered a financing crisis. That is not what the numbers show. The message is that 2025 revealed how fragile the difference can be between "inside covenants" and "genuinely flexible" for a global industrial company carrying heavy inventory.

If in 2026 Ginegar manages to reduce short-term credit, stabilize supplier days, prevent further slippage in customer days, and bring operating cash flow back into positive territory, then 2025 will look like a bridge year in retrospect. If not, short-term bank debt will effectively become a permanent working-capital funder, and today's covenant cushion will look much less generous.

Bottom line: Ginegar's closing cash balance at the end of 2025 looks steadier than the year's real economics justify. Anyone measuring only the cash line misses the bridge that holds it up: heavy working capital, weaker supplier credit, a deeper move into short-term funding, and bank headroom that exists but rests on less rigid lines than the headline number implies.